Medication info

Jedin Tablet 150 mg (Ranitidine Hydrochloride)

Prescription medicationTabletOralExpired
Ingredient · strength
Ranitidine Hydrochloride›168mg / 1 tablet
Manufacturer / importer
Jongkundang Co., Ltd.
Appearance
White round film-coated tablet
Packaging
100 tablets (10 tablets/PTP x 10)
Approval status
Expired

MFDS item code 200000209 · Notified 2000.05.10

This product's status changed to Expired on 2025.04.01. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of acid-related disorders (such as ulcers), improvement of gastric mucosal lesions, prevention of Mendelson syndrome
Who takes it
Adults · Children
Adult dose
(Tablets) 150, 300 mg (Oral solution) 75 mg/sachet Administer 150 mg of ranitidine orally twice daily, in the morning and at bedtime. Gastric and duodenal ulcers: Administer 150 mg of this drug orally twice daily, or 300 mg once daily at bedtime. A higher cure rate may be achieved, particularly in patients with duodenal ulcers, by administering 300 mg twice daily, in the morning and at bedtime. The dosage and administration are the same for concurrent therapy to treat ulcers caused by nonsteroidal anti-inflammatory drugs or to prevent gastric and duodenal ulcers during long-term treatment with nonsteroidal anti-inflammatory drugs. Healing usually occurs within 4 weeks; conditions caused by nonsteroidal anti-inflammatory drugs usually heal within 8 weeks, although healing may occasionally take longer in some patients. Maintenance therapy for gastric and duodenal ulcers: For patients with recurrent ulcers who responded well to short-term therapy with this drug, administer 150 mg once daily at bedtime as maintenance therapy. Reflux esophagitis: Administer 150 mg of this drug twice daily for 8 weeks, or 300 mg once daily at bedtime. For patients with severe reflux esophagitis, the dose may be increased to 150 mg 4 times daily. Zollinger-Ellison syndrome: Initiate treatment with an initial dose of 150 mg of this drug 3 times daily, and increase the dose as needed. In severe cases, up to 6 g per day may be administered as directed by a physician. Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions: Treatment is usually initiated with an injection. Once oral administration is possible, switch to oral administration and give 150 mg of this drug twice daily. Premedication for anesthesia (prevention of Mendelson's syndrome): Administer 150 mg of this drug 2 hours before induction of anesthesia. In this case, it is preferable to also administer 150 mg on the night before surgery. Improvement of gastric mucosal lesions (erosions, bleeding, redness, and edema) associated with the following conditions: acute gastritis and acute exacerbation of chronic gastritis: Administer 150 mg of this drug once daily at bedtime. For patients with severe renal impairment and creatinine clearance of 50 mL/min or less, administer 150 mg once daily at bedtime. Depending on the patient's condition, the dosing interval may be extended to 12 hours or longer. Hemodialysis reduces the blood concentration of the drug; therefore, adjust the dosing schedule immediately after hemodialysis. The dose may be adjusted according to age and symptoms.
Child dose
Patients 12 years of age and older: For excess stomach acid, heartburn, and acid regurgitation, take 75 mg per dose orally twice daily (liquid formulation only). Ages 8 to 18 years: 150 mg per dose (2 mg per kg of body weight) may be taken up to twice daily.

Ingredients

Manufacturer
Jongkundang Co., Ltd.

Efficacy & effects

Treatment of acid-related disorders (such as ulcers), improvement of gastric mucosal lesions, prevention of Mendelson syndrome

  • Gastric and duodenal ulcers
  • Zollinger-Ellison syndrome
  • gastroesophageal reflux disease
  • Mendelson syndrome
  • post-surgical ulcers
  • gastric and duodenal ulcers due to NSAID use
  • gastric mucosal lesions
  • erosion
  • bleeding
  • redness
  • swelling
  • acute gastritis
View approved original text

This medication is effective for conditions such as gastric and duodenal ulcers, Zollinger-Ellison syndrome, and gastroesophageal reflux disease. It is also used for the prevention of post-surgical ulcers and the treatment of gastric and duodenal ulcers caused by NSAID administration. Additionally, it helps improve gastric mucosal lesions in acute gastritis, acute exacerbations of chronic gastritis, and upper gastrointestinal bleeding. It is effective for relief of heartburn or belching symptoms due to excessive gastric acid, and is particularly convenient when taken in liquid form. Overall, this medication is used to improve gastric mucosal damage and regulate gastric acid secretion to enhance digestive health.

How to take

Adult dose

(Tablets) 150, 300 mg (Oral solution) 75 mg/sachet Administer 150 mg of ranitidine orally twice daily, in the morning and at bedtime. Gastric and duodenal ulcers: Administer 150 mg of this drug orally twice daily, or 300 mg once daily at bedtime. A higher cure rate may be achieved, particularly in patients with duodenal ulcers, by administering 300 mg twice daily, in the morning and at bedtime. The dosage and administration are the same for concurrent therapy to treat ulcers caused by nonsteroidal anti-inflammatory drugs or to prevent gastric and duodenal ulcers during long-term treatment with nonsteroidal anti-inflammatory drugs. Healing usually occurs within 4 weeks; conditions caused by nonsteroidal anti-inflammatory drugs usually heal within 8 weeks, although healing may occasionally take longer in some patients. Maintenance therapy for gastric and duodenal ulcers: For patients with recurrent ulcers who responded well to short-term therapy with this drug, administer 150 mg once daily at bedtime as maintenance therapy. Reflux esophagitis: Administer 150 mg of this drug twice daily for 8 weeks, or 300 mg once daily at bedtime. For patients with severe reflux esophagitis, the dose may be increased to 150 mg 4 times daily. Zollinger-Ellison syndrome: Initiate treatment with an initial dose of 150 mg of this drug 3 times daily, and increase the dose as needed. In severe cases, up to 6 g per day may be administered as directed by a physician. Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions: Treatment is usually initiated with an injection. Once oral administration is possible, switch to oral administration and give 150 mg of this drug twice daily. Premedication for anesthesia (prevention of Mendelson's syndrome): Administer 150 mg of this drug 2 hours before induction of anesthesia. In this case, it is preferable to also administer 150 mg on the night before surgery. Improvement of gastric mucosal lesions (erosions, bleeding, redness, and edema) associated with the following conditions: acute gastritis and acute exacerbation of chronic gastritis: Administer 150 mg of this drug once daily at bedtime. For patients with severe renal impairment and creatinine clearance of 50 mL/min or less, administer 150 mg once daily at bedtime. Depending on the patient's condition, the dosing interval may be extended to 12 hours or longer. Hemodialysis reduces the blood concentration of the drug; therefore, adjust the dosing schedule immediately after hemodialysis. The dose may be adjusted according to age and symptoms.

Child dose

Patients 12 years of age and older: For excess stomach acid, heartburn, and acid regurgitation, take 75 mg per dose orally twice daily (liquid formulation only). Ages 8 to 18 years: 150 mg per dose (2 mg per kg of body weight) may be taken up to twice daily.

Precautions

This medication should not be used in patients with a known allergy to any of its components or those with a history of acute porphyria. It should be used cautiously in patients with impaired kidney function, as the drug may remain in the body longer; thus, dosage reduction or extended dosing intervals is necessary. Caution is also advised for patients with compromised liver function or a history of drug allergies, elderly patients, and those taking NSAIDs. Particularly, patients with gastric ulcers or those over middle age who have newly developed or experienced changes in dyspeptic symptoms should confirm the possibility of gastric cancer before using this medication. This drug should be administered in conjunction with eradication therapy for patients with gastric or duodenal ulcers caused by Helicobacter pylori. Severe allergic reactions, such as anaphylactic shock, may occur rarely; any unusual symptoms should prompt immediate cessation of the medication and consultation with healthcare professionals. Blood tests may reveal abnormalities such as leukopenia and thrombocytopenia; notify a hospital immediately if you experience weakness, bleeding, or fever. The liver function may deteriorate temporarily; if symptoms such as jaundice, fatigue, or loss of appetite occur, stop the medication and consult a physician. Arrhythmias, vasculitis, gastrointestinal symptoms (constipation, nausea, abdominal pain, etc.), and neuropsychiatric symptoms (dizziness, drowsiness, confusion, etc.) may also occur rarely, necessitating caution. This drug has been reported to cause side effects such as gynecomastia, erectile dysfunction, myalgia, and skin rashes, so seek immediate medical advice if you have any unusual symptoms. Elderly patients or those with reduced kidney function may have higher blood drug concentrations, requiring dosage adjustments. While taking this medication, if dizziness or drowsiness occurs, avoid driving or operating hazardous machinery. Interactions with other drugs may occur, so always inform your healthcare provider of any medications you are taking, especially anticoagulants like warfarin, and regularly monitor blood coagulation status when using them concurrently. Women who are pregnant or may become pregnant and breastfeeding mothers should only use this medication after careful consideration when absolutely necessary. The safety for use in children has not been fully established, so special caution is warranted.

Side effects

  • anaphylactic shock
  • urticaria
  • angioedema
  • rash
  • fever
  • bronchospasm
  • hypotension
  • chest pain
  • granulocytopenia
  • elevated serum creatinine
Show 57 more
  • leukopenia
  • thrombocytopenia
  • bone marrow suppression
  • aplastic anemia
  • refractory anemia
  • agranulocytosis
  • pancytopenia
  • acquired immune hemolytic anemia
  • eosinophilia
  • generalized fatigue
  • weakness
  • subcutaneous·mucosal bleeding
  • liver dysfunction
  • jaundice
  • hepatitis
  • bradycardia
  • heart block
  • tachycardia
  • vasculitis
  • constipation
  • nausea
  • vomiting
  • abdominal distension
  • abdominal pain
  • appetite loss
  • diarrhea
  • acute pancreatitis
  • dizziness
  • drowsiness
  • convulsions
  • headache
  • heaviness of the head
  • insomnia
  • agitation
  • anxiety
  • mental confusion
  • depression
  • hallucinations
  • blurred vision
  • involuntary movement disorders
  • consciousness disorders
  • hepatomegaly muscle spasms
  • gynecomastia
  • excessive lactation
  • erectile dysfunction
  • decreased libido
  • arthralgia
  • myalgia
  • rhabdomyolysis
  • skin rash
  • erythema multiforme
  • alopecia
  • stomatitis
  • pruritus
  • mucous membrane syndrome
  • toxic epidermal necrolysis
  • acute interstitial nephritis

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a tightly sealed container to prevent air exposure, at room temperature between 1 to 30 degrees Celsius. Proper storage helps maintain the drug's effectiveness and prevents degradation.

Appearance and packaging

Appearance

White round film-coated tablet

Package unit

100 tablets (10 tablets/PTP x 10)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.